Glanish Jude Martis and Santosh L. Gaonkar
RSC Adv., 2025,15, 8213-8243
From themed collection:
2025 Reviews in RSC Advances
Abstract
Recent advances in synthetic strategies of isoxazoles and their role in medicinal chemistry.
Afia Saleem, Hamza Khan, Syed Majid Bukhari, Lotfi Ben Tahar, Umar Farooq and Ahson Jabbar Shaikh
Dalton Trans., 2025,54, 16508-16524
Abstract
Lone pair electrons dominate the binding of isoxazole derivatives to metal oxide surfaces, while aromatic groups show reduced affinity, revealing a fundamental shift from metal to metal oxide surface interactions.
Martina Piškor, Marina Ter, Leentje Persoons, Dirk Daelemans, Ahmed Adel, Mutasem O. Taha, Astrid Milić, Mirela Sedić and Silvana Raić-Malić
RSC Adv., 2025,15, 50633-50651
Abstract
Resistance to conventional therapies in pancreatic and hematologic malignancies highlights the need for novel agents that selectively induce tumor cell death.
Neha Jangra, Bharti Sharma, Deepak Kumar and Archana Kapoor
RSC Med. Chem., 2025,16, 3893-3958
Abstract
The study summarizes the findings from the last eight years of research on heterocyclic core-based epidermal growth factor receptor inhibitors. This provides an invaluable tool for oncology drug discovery.
Xin-Qi Zhu, Zhi-Xu Meng, Bo Zhou, Ming-Yu Teng and Long-Wu Ye
Chem. Soc. Rev., 2025,54, 2137-2153
Abstract
This review summarizes the latest trends and developments of isoxazole-enabled alkyne amination reactions and their applications in divergent heterocycle synthesis.